These EGFR-activating mutations, also called EGFR-sensitizing mutations, make cancer cells become dependent upon the EGFR signaling pathway and stimulate cancer cell proliferation, angiogenesis, and the evasion of apoptosis by activating downstream effectors [4]. Here, EGFR is linked to cancer.